Matches in Wikidata for { <http://www.wikidata.org/entity/Q94912816> ?p ?o ?g. }
- Q94912816 description "2020 nî lūn-bûn" @default.
- Q94912816 description "2020年の論文" @default.
- Q94912816 description "2020年学术文章" @default.
- Q94912816 description "2020年学术文章" @default.
- Q94912816 description "2020年学术文章" @default.
- Q94912816 description "2020年学术文章" @default.
- Q94912816 description "2020年学术文章" @default.
- Q94912816 description "2020年学术文章" @default.
- Q94912816 description "2020年學術文章" @default.
- Q94912816 description "2020年學術文章" @default.
- Q94912816 description "2020年學術文章" @default.
- Q94912816 description "2020年學術文章" @default.
- Q94912816 description "2020年學術文章" @default.
- Q94912816 description "2020년 논문" @default.
- Q94912816 description "article científic" @default.
- Q94912816 description "article scientific" @default.
- Q94912816 description "article scientifique" @default.
- Q94912816 description "articol științific" @default.
- Q94912816 description "articolo scientifico" @default.
- Q94912816 description "artigo científico" @default.
- Q94912816 description "artigo científico" @default.
- Q94912816 description "artigo científico" @default.
- Q94912816 description "artikel ilmiah" @default.
- Q94912816 description "artikull shkencor" @default.
- Q94912816 description "artikulong pang-agham" @default.
- Q94912816 description "artykuł naukowy" @default.
- Q94912816 description "artículo científico publicado en 2020" @default.
- Q94912816 description "artículu científicu" @default.
- Q94912816 description "bilimsel makale" @default.
- Q94912816 description "bài báo khoa học" @default.
- Q94912816 description "naučni članak" @default.
- Q94912816 description "scienca artikolo" @default.
- Q94912816 description "scientific article published on 14 May 2020" @default.
- Q94912816 description "scientific article published on 14 May 2020" @default.
- Q94912816 description "scientific article published on 14 May 2020" @default.
- Q94912816 description "teaduslik artikkel" @default.
- Q94912816 description "tieteellinen artikkeli" @default.
- Q94912816 description "tudományos cikk" @default.
- Q94912816 description "vedecký článok" @default.
- Q94912816 description "vetenskaplig artikel" @default.
- Q94912816 description "videnskabelig artikel udgivet 14. maj 2020" @default.
- Q94912816 description "vitenskapelig artikkel" @default.
- Q94912816 description "vitskapeleg artikkel" @default.
- Q94912816 description "vědecký článek" @default.
- Q94912816 description "wetenschappelijk artikel" @default.
- Q94912816 description "wissenschaftlicher Artikel" @default.
- Q94912816 description "επιστημονικό άρθρο" @default.
- Q94912816 description "мақолаи илмӣ" @default.
- Q94912816 description "наукова стаття, опублікована в травні 2020" @default.
- Q94912816 description "научна статия" @default.
- Q94912816 description "научная статья" @default.
- Q94912816 description "научни чланак" @default.
- Q94912816 description "научни чланак" @default.
- Q94912816 description "מאמר מדעי" @default.
- Q94912816 description "مقالة علمية نشرت في 14 مايو 2020" @default.
- Q94912816 description "১৪ মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q94912816 description "บทความทางวิทยาศาสตร์" @default.
- Q94912816 description "სამეცნიერო სტატია" @default.
- Q94912816 name "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 name "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 type Item @default.
- Q94912816 label "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 label "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 prefLabel "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 prefLabel "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 P1433 Q94912816-F5900A0D-2B96-412E-A528-1F34E95AA647 @default.
- Q94912816 P1476 Q94912816-8342A77C-658E-4380-A9BF-3371708B3DFB @default.
- Q94912816 P2093 Q94912816-04218750-7A9C-44B7-8A82-8546AAE14B8B @default.
- Q94912816 P2093 Q94912816-0BDCE0D5-B27E-494C-BEBE-2DD6BB2F453A @default.
- Q94912816 P2093 Q94912816-1443E2C8-FD74-4D2A-A8C9-B7B23CFA8525 @default.
- Q94912816 P2093 Q94912816-1E343D01-F290-4A2E-99B9-A474FB9806C2 @default.
- Q94912816 P2093 Q94912816-326FBB2E-0CC7-47B1-8608-A9ECB9D204B8 @default.
- Q94912816 P2093 Q94912816-4835499F-5843-4588-874E-B7D69D65C2CD @default.
- Q94912816 P2093 Q94912816-4B2CCFDF-B5E6-4571-B624-74CB6EABF428 @default.
- Q94912816 P2093 Q94912816-7E19DD57-9D69-4E10-957A-AE15640F4F61 @default.
- Q94912816 P2093 Q94912816-967D3110-2B87-4215-B266-F7BDB8C49DE1 @default.
- Q94912816 P2093 Q94912816-9731864F-2CB1-4FCF-8AD9-3B3032F7B10B @default.
- Q94912816 P2093 Q94912816-B7CAF759-F980-461C-A0DA-D61EF3F5B7A9 @default.
- Q94912816 P2093 Q94912816-BC25F596-8806-41AF-ABA0-78F586282D24 @default.
- Q94912816 P2093 Q94912816-BF1E8C41-3C11-4007-ADF3-5E66F0CEC5E9 @default.
- Q94912816 P2093 Q94912816-C7C91B6B-B129-4409-9D09-06F83287EC79 @default.
- Q94912816 P2093 Q94912816-CA2CEDDD-ECB3-4F55-9536-D75175699AF5 @default.
- Q94912816 P2093 Q94912816-E557567E-B2AC-448F-906D-91423EEB3ABA @default.
- Q94912816 P2093 Q94912816-F83A3F81-231E-42A6-977E-1A0882565F5A @default.
- Q94912816 P2860 Q94912816-31EE7BEC-74CB-4E4F-B045-8FEEA07E9972 @default.
- Q94912816 P31 Q94912816-FB51C21A-8799-4282-8C9D-929AEF4F76BA @default.
- Q94912816 P356 Q94912816-E5D3697F-8225-47BA-ABD2-A75605239E05 @default.
- Q94912816 P577 Q94912816-61E8B73E-9E15-490C-988E-555FC4C48696 @default.
- Q94912816 P698 Q94912816-7EE1A1ED-664C-4C3B-A997-9189E4A36E33 @default.
- Q94912816 P921 Q94912816-1A40B3AC-EBA7-4EED-9D66-66186316A5F7 @default.
- Q94912816 P921 Q94912816-796208B5-EF85-4732-AE16-87ED7D2C33E6 @default.
- Q94912816 P356 S10637-020-00928-Z @default.
- Q94912816 P698 32410080 @default.
- Q94912816 P1433 Q2312231 @default.
- Q94912816 P1476 "A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment" @default.
- Q94912816 P2093 "Andrea Myers" @default.
- Q94912816 P2093 "Andrés Cervantes" @default.
- Q94912816 P2093 "Guillem Argilés" @default.
- Q94912816 P2093 "Huai-Xiang Hao" @default.
- Q94912816 P2093 "Jean-Pierre Delord" @default.